Stock research
AEMD Aethlon Medical, Inc.
Healthcare • Medical - Devices
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States....…
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.
ALL change
-99.98%
Range high
$21,040.00
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in AEMD?
Price
Showing ALL history. Source: FMP historical price full.
- Prev Close
- $3.52
- Day High
- $3.70
- Day Low
- $3.21
- 52w High
- $137.00
- 52w Low
- $2.63
- Volume
- 146,625
- Avg Volume
- Beta
- 1.41
* TTM/most recent where available
Company
- Ticker
- AEMD
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
- CEO
- James Frakes
- Employees
- 9
- Website
- www.aethlonmedical.com
Key Metrics
- Market Cap
- 1.73M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).